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Abstract Several novel prokaryotic and eukaryotic expression
vectors were constructed for protein transduction and subcellu-
lar localization. These vectors employed an N-terminal stretch
of 11 basic amino acid residues (47^57) from the human immu-
node¢ciency virus type 1 (HIV-1) TAT protein transduction
domain (PTD) for protein translocation and cellular localiza-
tion. The vectors also contained a six-histidine (His6) tag at the
N- or C-terminus for convenient puri¢cation and detection, and
a multiple cloning site for easy insertion of foreign genes. Some
heterologous genes including HSV-TK, Bcl-rambo, Smac/DIA-
BLO and GFP were fused in-frame to TAT PTD and success-
fully overexpressed in Escherichia coli. The puri¢ed TAT-GFP
fusion protein was able to transduce into the mammalian cells
and was found to locate mainly in the cytosol when exogenously
added to the cell culture medium. However, using a transfection
system, mammalian-expressed TAT-GFP predominantly dis-
played a nuclear localization and nucleolar accumulation in
mammalian cell lines. This discrepancy implies that the exact
subcellular localization of transduced protein may depend on
cell type, the nature of imported proteins and delivery approach.
Taken together, our results demonstrate that a TAT PTD
length of 11 amino acids was su⁄cient to confer protein inter-
nalization and its subsequent cellular localization. These novel
properties allow these vectors to be useful for studying protein
transduction and nuclear import.
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lished by Elsevier Science B.V. All rights reserved.
Key words: Human immunode¢ciency virus type 1 TAT;
Protein transduction domain; Nuclear localization signal
1. Introduction
E⁄cient intracellular delivery and correct localization of
pharmaceutical macromolecules remains problematic because
of the barrier of impermeable cell membranes. In 1988, how-
ever, Green and Frankel independently discovered that hu-
man immunode¢ciency virus type 1 (HIV-1)-encoded trans-
activator TAT protein, an 86-amino acid protein which is
essential for viral gene expression and replication, could rap-
idly enter cells, even the nucleus, and subsequently trans-acti-
vate the viral long terminal repeat promoter when added exo-
genously to the culture medium [1,2]. From then on, increas-
ing evidence has shown that TAT protein is capable of medi-
ating heterologous proteins across the plasma membrane into
nearly all eukaryotic cells [3]. This unique transport mode is
not receptor-, transporter-, or endocytosis-dependent, rather it
is concentration-dependent [4]. Thus far, the exact mechanism
by which TAT-linked proteins can freely enter cells still re-
mains unclear. Nevertheless, several other proteins with a
protein transduction domain (PTD), including ANTP from
Drosophila and VP22 from herpes simplex virus (HSV), have
been identi¢ed [5]. Previous studies have shown that the 11-
amino acid TAT peptide YGRKKRRQRRR (residues 47^57),
rich in basic amino acids (highlighted in bold), is su⁄cient for
intracellular transduction and subcellular localization [6,7]. It
is believed that this short TAT motif can functionally be dis-
sected into two parts: GRKKR can act as a potential nuclear
localization signal (NLS), whereas RRR appears to be very
critical for protein translocation [6]. Recently, Dowdy’s group
have conducted many pioneer researches in this ¢eld and have
developed the bacterial expression vector pTAT/TAT-HA for
this purpose [7]. In addition, using a transfection system and
indirect immuno£uorescence analysis, Ruben et al. [8] and
Hauber et al. [9] reported that TAT protein was localized
predominantly in the nucleus, with accumulation especially
within the nucleolus. The enhanced green £uorescent protein
(GFP) is widely used as a marker for monitoring gene expres-
sion and cellular localization; we therefore employed this £uo-
rescent protein to generate TAT-GFP fusion protein to ad-
dress the intracellular transduction and subcellular location of
TAT PTD in mammalian cells.
In order to facilitate the investigation of the mechanism of
TAT-mediated protein delivery into cells and subsequent sub-
cellular localization, we developed several novel prokaryotic
and eukaryotic expression vectors, in which an 11-amino acid
HIV-1 TAT PTD or a TAT PTD mutant (TAT-m) with six
amino acid substitutions within the TAT peptide, YAR-
AAARQARA, was included [10]. The HSV thymidine kinase
(TK) gene, the enhanced GFP gene and two mammalian pro-
apoptotic genes, Bcl-rambo [11] and Smac/DIABLO [12,13],
were tested for their overproduction in Escherichia coli. Bac-
terially expressed TAT-Smac/DIABLO and TAT-GFP could
be successfully taken up by the target cells. It is interesting to
note that the imported TAT-Smac/DIABLO did not appear
to localize in the cytosol, whereas the TAT-GFP was largely
observed in the cytosol when exogenously added to the cul-
tured cells. Using a transfection system, however, TAT-GFP
was showed to localize mainly in the nucleus and accumulate
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in the nucleolus in all mammalian cells tested. In contrast to
TAT PTD, mutant TAT-m completely abolished its nuclear
localization.
2. Materials and methods
2.1. Oligonucleotides
All primers used in this study are listed as follows. Restriction
enzyme sites incorporated to facilitate cloning are underlined. Pnkb1
5P-AACATATGTACGGTCGTAAAAAACGTCGTCAGCGTCGT-
CGTGGTACCATGGCTTCGTACCCCTGCCA-3P (NdeI, KpnI),
Pnkb2 5P-AACATATGTACGCTCGTGCTGCTGCTCGTCAGGC-
TCGTGCTGGTACCATGGCTTCGTACCCCTGCCA-3P (NdeI,
KpnI), Pnkb3 5P-AACATATGGGTACCATGGCTTCGTACCCCT-
GCCA-3P (NdeI, KpnI), Pnkb4 5P-CGGGATCCGAGGTACCGTG-
AGCCTCCCCCATCTCCC-3P (BamHI, KpnI), Ptk1 5P-GAA-
GATCTGCCACCATGGGCAGCAGCCAT-3P (BglII) and Ptk2
5P-CCGCTCGAGGGTACCTCAGTGAGCCTCCCCCATCTC-3P
(XhoI, KpnI).
2.2. Construction of vectors
pET-22b(+), pET-15b (Novagen) and pEGFP-N1 (Clontech) were
the parental plasmids for construction of various prokaryotic and
eukaryotic expression vectors. Using plasmid pAdbm5-TK bearing
the HSV-TK gene as a template, primer pairs Pnkb1/Pnkb4, Pnkb2/
Pnkb4 and Pnkb3/Pnkb4 were used for ampli¢cation of the TAT-TK,
TAT-m-TK and TK gene fragments respectively. The three resultant
PCR products were digested with NdeI/BamHI and subcloned into
pET-22b(+) to generate plasmids named pNKB-1, pNKB-2 and
pNKB-3. These plasmids were digested with NdeI and XhoI, and
the smaller segments containing the TAT-TK, TAT-m-TK and TK
coding regions were ligated into pET-15b to create pNKB-11, pNKB-
12 and pNKB-13. These six plasmids were cleaved with KpnI to re-
move the TK gene, and the resultant larger fragments were self-reli-
gated to yield six di¡erent vectors designated pETAT-1, pETAT-2
and pNB-3 (pET-22b(+)-based) and pETAT-11, pETAT-12 and
pNB-13 (pET-15b-based). To generate eukaryotic expression vectors,
we designed two primers Ptk1 and Ptk2. Forward primer Ptk1 cor-
responded to the region upstream of the six-histidine (His6) tag with
which three bases were overlapping and reverse primer Ptk2 was
made to complement the 3P region of the HSV-TK gene. Using
pNKB-11, pNKB-12 and pNKB-13 as templates, we successfully am-
pli¢ed three PCR products, which were then digested and subcloned
into the BglII and XhoI sites of pAdTrack-CMV [14] to generate
plasmids pAd/His-TAT-TK, pAd/His-TAT-m-TK and pAd/His-TK.
The resultant recombinant plasmids were further digested with KpnI
to remove the HSV-TK gene, and self-religated again to yield pAd/
His-TAT, pAd/His-TAT-m and pAd/His. The smaller BglII- and
XhoI-digested fragments released from these plasmids were inserted
into the same sites of pEGFP-N1 to generate pHis-TAT-GFP, pHis-
TAT-m-GFP and pHis-GFP. The nucleotide sequences of all PCR
products were con¢rmed by the ABI Prism automated sequencing
method.
2.3. Expression and puri¢cation of TAT fusion proteins
The recombinant prokaryotic plasmids were transformed into E.
coli strain BL21 (DE3) to express fusion proteins with or without
TAT PTD. The bacteria were grown to reach an OD600 of approx-
imately 0.5^0.8 prior to induction. For expression of TAT-TK, TAT-
Bcl-rambo and TAT-GFP, cells were induced with 1 mM isopropyl-L-
D-thiogalactoside (IPTG) for 3^6 h, for expression of TAT-Smac, cells
were induced with 0.1 mM IPTG for 6 h. The cells were then har-
vested, suspended in binding bu¡er (20 mM Tris^HCl, pH7.9, 0.5 M
NaCl) and sonicated. The solubilized TAT-Smac fusion protein was
puri¢ed under native conditions, and TAT-GFP was puri¢ed under
denatured and native conditions respectively. To denature TAT-GFP
fusion protein, the harvested cells were sonicated in binding bu¡er
containing 8 M urea. The fusion proteins were puri¢ed by Ni2þ af-
¢nity chromatography using a chelating Sepharose resin column
(Pharmacia). After the column was washed with 100 mM imidazole
in binding bu¡er, the fusion protein was eluted with 1 M imidazole in
binding bu¡er. The fusion protein in either native or denatured form
was then concentrated, desalted and bu¡er exchanged to phosphate-
bu¡ered saline (PBS) using a stirred ultra¢ltration cell (Millipore), the
puri¢ed fusion protein could be used directly for protein transduction
or aliquoted and stored frozen in 10% glycerol at 380‡C [15,16].
For the transduction of TAT fusion proteins, cells were cultured to
70^80% con£uence in 24-well microtiter plates. Just before transduc-
tion, the culture media were removed and replaced by 0.5 ml fresh
medium, to which TAT fusion proteins at various concentrations were
then added. After incubation for indicated intervals, the cells were
washed with PBS at least four to ¢ve times to avoid possible aggre-
gation of proteins. Cells were then examined directly by £uorescence
microscopy and further used for Western blot analysis.
2.4. Cell death assay
The MTT assay was used to determine cell viability. Brie£y, A549
cells were plated at 1U104cells/well in 96-well microtiter plates and
incubated overnight. After replacement with fresh medium, cells were
treated with TAT-Smac or Smac at ¢nal concentrations of 100 nM,
200 nM and 400 nM for 6 h. Taxol was added to the media at a ¢nal
concentration of 100 nM and incubated for another 10 h followed by
addition of 10 Wl of 5 mg/ml MTT solution. After incubation, the
media were removed and replaced with 100 Wl dimethyl sulfoxide
and the data were analyzed using an ELX800 Universal Microplate
Reader (Bio-Tek Instruments) at a wavelength of 570 nm. The e¡ect
of cell death was normalized as a percentage using cells treated with
taxol alone as control.
2.5. Cell cultures and transfections
Human glioblastoma cell line A172, human embryonic kidney cell
line 293T, human cervical cancer cell line HeLa and monkey kidney
cell line COS-7 were cultured in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal bovine serum (FBS) and antibiotics pen-
icillin (100 U/ml)/streptomycin (0.1 mg/ml) at 37‡C in 5% CO2. Hu-
man lung carcinoma cell line A549 and rat glioma cell line C6 were
grown in RPMI 1640 medium containing 10% fetal calf serum (FCS)
and penicillin (100 U/ml)/streptomycin (0.1 mg/ml) and maintained at
37‡C/5% CO2. Transfections of cells were performed using Lipofect-
amine 2000 (Invitrogen) according to the manufacturer’s speci¢ca-
tions.
2.6. Western blot analysis
Western blot was carried out mainly according to the manufactur-
er’s instructions. Brie£y, cells were harvested, washed twice with cold
PBS (pH 7.4) and then resuspended in lysis bu¡er (50 mM Tris^HCl
(pH 7.5), 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 0.5% NP-40)
supplemented with protease inhibitor cocktail (Roche) on ice for 30
min. The lysate was centrifuged, and supernatants and pellets were
mixed with an equal volume of 2ULaemmli’s bu¡er respectively. The
samples were loaded and separated by 12% SDS^polyacrylamide gel.
The resolved proteins were transferred onto a nitrocellulose mem-
brane (Amersham). The blot was blocked with 5% milk in Tris-bu¡-
ered saline+Tween (TBST) and then incubated with mouse anti-GFP
polyclonal antibody (Clontech) or anti-His polyclonal antibody (San-
ta Cruz) for 1 h at room temperature. After washing three times with
TBST, the membrane was incubated with alkaline phosphatase-con-
jugated goat anti-mouse immunoglobulin (Promega). The membrane
was washed three times with TBST followed by two brief washes with
TBS. The proteins were visualized by using Western Blue stabilized
Substrate for alkaline phosphatase (Promega).
2.7. Visualization of GFP £uorescence
Cells were observed with an inverse £uorescence microscope (Olym-
pus IX70) equipped with a FITC ¢lter set, using a U20 objective for
examination of cultures grown on dishes. Fluorescence images were
captured using Spot software version 3.0 (Diagnostic Instruments)
and Adobe Photoshop version 6.0.
3. Results and discussion
3.1. Features of constructed vectors
Three pET-22b(+)-based and three pET-15b-based vectors
were developed for high-level expression and puri¢cation of
heterologous TAT PTD fusion proteins in E. coli (Table 1),
and the resultant puri¢ed proteins can be further used for the
study of protein transduction. As shown in Fig. 1, pETAT-1/2
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and pETAT-11/12 all contained an N-terminal 11-amino acid
TAT PTD or TAT-m for protein intracellular translocation.
To enhance the translation initiation of fusion proteins, all the
codons encoding TAT peptide were altered to the most pre-
ferred ones used in the E. coli system. An optional N- or C-
terminal His6 tag allowed in-frame fusion proteins to be read-
ily puri¢ed by Ni2þ a⁄nity chromatography and detected
with anti-His antibody. These vectors also contained a multi-
ple cloning site (MCS) for easy insertion of target genes.
Compared with the MCS in their original parental vectors,
there was little, if any, modi¢cation in pET-22b(+)-based vec-
tors, whereas a few additional cloning sites were added in
pET-15b-based vectors. More importantly, not only these
added sites in MCS are in-frame with polylinkers in their pa-
rental vectors, but also the MCS in pET-15-based vectors and
in pET-22b(+)-based vectors are interchangeable. Further-
more, an additional Gly residue was inserted between TAT
PTD and MCS for free bond rotation of TAT PTD [7]. Plas-
mids pNB-3 and pNB-13 were identical to pETAT-1/2 and
pETAT-11/12 vectors except for being without TAT PTD
and TAT-m.
In addition, three pEGFP-N1-based eukaryotic expression
vectors were also developed for studying subcellular localiza-
tion of TAT PTD hybrid proteins (Table 1). As shown in Fig.
1, a Kozak consensus sequence (GCCACCATGG), embedded
with an NcoI site and an ATG start codon, was introduced
immediately upstream of the His6 tag to further enhance the
translation e⁄ciency of fusion proteins. TAT PTD occurred
just upstream of the MCS. The gene of interest can be cloned
into MCS to fuse in-frame to TAT PTD and GFP at the C-
terminus simultaneously. Using GFP as an indicator has dis-
tinct advantages over other detection systems such as anti-
body detection, which requires both cell ¢xing and cell killing
and often leads to the production of artifacts in the pattern of
localization. Most notably, GFP permits a non-invasive local-
ization study in real time using living cells. In case of the non-
GFP fusion studies, the GFP gene can be readily removed.
3.2. High-level expression of TAT fusion proteins in
constructed prokaryotic vectors
To demonstrate the utilities of vectors, several heteroge-
neous genes including the full-length HSV-TK gene, the en-
hanced GFP gene, the truncated human Bcl-rambo cDNA
fragment (613^1455 bp) and the N-terminally deleted human
Smac cDNA fragment (55^717 bp) were cloned respectively
into these vectors and expressed in E. coli BL21 (DE3) cells
(Figs. 2 and 4). Compared with controls, induced proteins
were displayed as prominent bands and accounted for approx-
imately 30% of total cellular proteins. As shown in Fig. 2B,
E. coli-expressed TAT-Bcl-rambo showed a apparent unusual
migration with a 20^30-kDa increase, which is not surprising
because a similar migration pattern was also observed in
mammalian cells by Kataoka et al. [11]. Although the true
reason for this retarded migration remains unknown, the pos-
sibility of phosphorylation of Bcl-rambo protein cannot be
dismissed. It is worthwhile to point out that although the
HSV-TK gene failed to be expressed in pNKB-3, it can be
highly expressed in pNKB-13 when the His6 tag is fused to the
N-terminus of HSV-TK. It seems unlikely that the expressed
HSV-TK was unstable and susceptible to proteolytic degrada-
tion. The alternative explanation is that we had observed sev-
eral rare codons residing in the 5P end of the HSV-TK coding
region, which may eliminate protein translation. The trans-
lation barrier is probably overcome by the e⁄cient translation
initiation of the His6 tag as a fusion ahead of HSV-TK [17].
Additionally, while expressed Bcl-rambo and GFP were found
mostly in soluble form, expressed HSV-TK and Smac/DIA-
BLO, whether fused with or without TAT PTD, remained
largely in inclusion bodies (data not shown), suggesting that
the status of solubility is dependent on the intrinsic properties
of the protein itself.
3.3. TAT-Smac is able to enter cultured A549 cells
To test the capability of transduction for TAT PTD, E. coli-
expressed Smac fusion proteins with or without TAT PTD
were puri¢ed under native conditions as described in Section
2. TAT-Smac and Smac were added directly to the cultured
A549 cells at a ¢nal concentration of 400 nM, and treated
cells were harvested at indicated time points followed by
Western analysis. We also incubated A549 cells with TAT-
Smac and Smac at various concentrations for 3 h and levels
of transduced proteins were analyzed by Western blot. As
shown in Fig. 3, TAT-Smac translocation into A549 cells
was time- (Fig. 3A) and dose- (Fig. 3B) dependent. TAT-
Smac was detected only in the lysate pellet but not in the
lysate supernatant, indicating that TAT-Smac probably ex-
isted in the nucleus. In contrast, Smac without TAT PTD
could not be detected either in the pellet or in the supernatant
(data not shown). To further examine whether transduced
TAT-Smac still retains its pro-apoptotic activity, the MTT
cell death assay was performed. As shown in Fig. 3C, A549
cells incubated with TAT-Smac (200 nM) in the presence of
taxol (100 nM) showed considerable cell death (45%), when
compared with cells treated with Smac lacking the TAT PTD
(200 nM), which gave rise to 30% of cell death. The relatively
higher background cell death may be attributed to the toxicity
Table 1
Plasmids constructed in the present study
Plasmid Host cell Selection (prok./euk.) Promoter TAT PTD His6 tag
pETAT-1 P Amp/none T7lac WT C
pETAT-2 P Amp/none T7lac M C
pNB-3 P Amp/none T7lac ^ C
pETAT-11 P Amp/none T7lac WT N
pETAT-12 P Amp/none T7lac M N
pNB-13 P Amp/none T7lac ^ N
pHis-TAT-GFP E Kan/Neo CMV/IE WT N
pHis-TAT-m-GFP E Kan/Neo CMV/IE M N
pHis-GFP E Kan/Neo CMV/IE ^ N
P, prokaryotic; E, eukaryotic; Amp, ampicillin; Kan, kanamycin; Neo, neomycin; CMV/IE, human cytomegalovirus immediate early pro-
moter; WT, wild-type; M, mutation; C, C-terminus; N, N-terminus.
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TCGAGCACCACCACCACCACCAC TGAAGA…3´ 
XhoI 
AvaI 
 
pNB-13 
                                                                               
5´…ACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCG 
NcoI
 
GCAGCCATATGGGTACCTCGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGC 
NdeI   KpnI        BamHI  EcoRI    SacI     SalI   HindIII     NotI 
 
ACTCGAGGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCAC 
   XhoI  BamHI 
 
CGCTGAGCAATAACTA…3´ 
 
pHis-GFP  
 
5´…CTCAGATCTGCCACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCT 
BglII          NcoI 
 
GGTGCCGCGCGGCAGCCATATGGGTACCCTCGAGCTCAAGCTTCGAATTCTGCAGTCG 
NdeI  KpnI      XhoI SacI   HindIII   EcoRI  PstI   SalI 
AccI 
                                                   
ACGGTACCGCGGGCCCGGGATCCACCGGTCGCCACCATGGTG…3´ 
    KpnI  SacII ApaI XmaI BamHI   AgeI   
                    SmaI 
pETAT-1/11 and pHis-TAT-GFP         
5´…ATGTACGGTCGTAAAAAACGTCGTCAGCGTCGTCGTGGT…3´ 
pETAT-2/12 and pHis-TAT-m-GFP      
5´…ATGTACGCTCGTGCTGCTGCTCGTCAGGCTCGTGCTGGT…3´ 
B
 
pNB-3 
 
5´…CATATGGGTACCTCGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCAC 
NdeI    KpnI       BamHI  EcoRI    SacI      SalI   HindIII    NotI 
EagI   
 
A
Fig. 1. Schematic maps of vectors (A) and nucleotide sequences present in the cloning/expression regions (B). ATG start codon and stop co-
dons are shown in bold. The underlined sequence represents the Kozak consensus sequence. The shaded sequence indicates the His6 tag. The
boxed sequence denotes the variable region. The boxed nucleotide sequences for TAT and TAT-m are shown in bold. Unique sites located in
MCS are shown in bold. The BamHI sites in pET-15b-based vectors and the KpnI sites in pEGFP-N1-based vectors can also be used for the
insertion of DNA fragments into these vectors.
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of exogenously added Smac. The result that transduced TAT-
Smac did not yield remarkable cell death was not unexpected,
since Smac/DIABLO by itself is a weak pro-apoptotic factor,
it can only potentiate apoptosis induced by diverse stimuli.
Thus we have demonstrated that transduced TAT-Smac was
able to promote taxol-induced cell death.
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Fig. 3. Transduction of TAT-Smac fusion protein into cultured
A549 cells in a time- (A) and dose- (B) dependent manner. TAT-
Smac (400 nM) was added to A549 culture media for 0, 1 and 2 h.
A549 cells were treated with 0, 100 and 400 nM of TAT-Smac for
3 h. The lysate pellet fractions were analyzed by Western blot. Mo-
lecular size of protein is indicated on the left. C: Transduced TAT-
Smac promoted cell death. A549 cells was incubated with TAT-
Smac or Smac for 6 h at ¢nal concentrations of 100, 200 and 400
nM, followed by induction of taxol at a ¢nal concentration of 100
nM for an additional 10 h. Cell death e¡ects were assessed by the
MTT assay. The e¡ect of cell death was normalized as a percentage
using cells treated with taxol alone as control.
6
Fig. 2. Expression and puri¢cation of TAT fusion proteins in E. coli.
A: Expression of TAT-TK with pNKB-1. Lane 1, uninduced; lane
2, induced. B: Expression of TAT-Bcl-rambo using pETAT-1 as a
vector. Lane 1, uninduced; lane 2, induced. C: Expression and puri-
¢cation of TAT-Smac using pETAT-1 as a vector. Lane 1, unin-
duced; lane 2, induced; lane 3, puri¢ed TAT-Smac. Molecular size
of protein is indicated on the left.
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Fig. 4. Transduction of E. coli-expressed TAT-GFP fusion protein into mammalian cells and its subcellular localization. A: Expression and pu-
ri¢cation of GFP with or without TAT PTD in E. coli. Upper panel: lane 1, uninduced control; lane 2, induced TAT-GFP; lane 3, induced
TAT-m-GFP; lane 4, induced GFP. Puri¢ed TAT-GFP, TAT-m-GFP and GFP are shown in the lower panel. B: Phase contrast images (a
and c) and corresponding £uorescence micrographs (b and d) of transduced TAT-GFP (a and b) or GFP (c and d) in A172 cells. a,b, dena-
tured TAT-GFP; c,d, denatured GFP. Arrows denote transduced TAT-GFP within the cells. C: Western blot of transduced TAT-GFP fusion
proteins. Both denatured and native TAT-GFP or GFP controls at a ¢nal concentration of 500 nM were added to cultured A172 cells for
12 h followed by Western blot analysis. Lane 1, native TAT-GFP; lane 2, denatured TAT-GFP; lane 3, native GFP; lane 4, denatured GFP.
Molecular size of protein is indicated on the left.
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3.4. E. coli-expressed TAT-GFP, but not GFP is capable of
transducing into cells
To further examine the usefulness of these vectors and the
synthetic TAT PTD, the enhanced GFP gene fragment from
pEGFP-N1 was subcloned into vectors pETAT-11, pETAT-
12 and pNB-13 and expressed in E. coli BL21 (DE3) cells
(Fig. 4A). We found these fusion proteins could be well ex-
pressed even without IPTG induction. The fusion proteins
could be easily monitored by its green £uorescence during
the entire protein expression and puri¢cation process. To
take advantage of the convenience of direct visualization of
GFP fusion proteins, we tested whether E. coli-expressed pro-
teins from our constructed vectors were able to transduce into
the mammalian cells. We incubated A172 cells with denatured
TAT-GFP and GFP control respectively and the results are
shown in Fig. 4B. Twelve hours after incubation, TAT-GFP
could be clearly detected within the A172 cells, indicating
TAT-GFP was capable of transducing into mammalian cells.
In addition, the transduced TAT-GFP was found to be
mainly located in the cytosol but not in the nucleus (Fig.
4B, a,b). In contrast, GFP control could not be detected in
these cells (Fig. 4B, c,d), suggesting the TAT PTD is required
for protein transduction. We also performed protein transduc-
tion using soluble TAT-GFP, and similar results were ob-
tained (data not shown), indicating that the folding state of
TAT-GFP might not be very critical for its protein transloca-
tion. The successful transduction was further con¢rmed by
Western blot analysis (Fig. 4C). Both native TAT-GFP
(lane 1) and denatured TAT-GFP (lane 2) can be detected
from total A172 cell lysates, whereas GFP control in either
of two forms was absent in A172 cell lysates (lanes 3 and 4).
Thus far, subcellular distribution of TAT-GFP still remains
controversial. Caron et al. [18] had reported that there was no
visible nuclear localization to be detected when denatured
TAT-eGFP protein was added into cultured muscle cells,
whereas Choi’s group [19] demonstrated that Tat (residues
49^57)-GFP fusion protein was able to distribute in both
the nucleus and the cytoplasm of Drosophila S2 cells. Our
results from TAT-GFP transduction in A172 cells are in
good agreement with those of Caron et al. These two di¡erent
observations may be explained by the fact that nuclear local-
ization is a complicated event in£uenced by many factors such
as the ¢ne structure of TAT PTD, denaturing and puri¢cation
conditions, folding state of TAT fusion polypeptides and the
host cell type.
3.5. TAT PTD is su⁄cient to confer nuclear localization and
nucleolar accumulation in transfected mammalian cells
To test the production of GFP fusion proteins with our
eukaryotic expression vectors, HEK293T cells were trans-
fected with pEGFP-N1, pHis-TAT-GFP, pHis-TAT-m-GFP
and pHis-GFP. Forty-eight hours after transfection, cells were
harvested, lysed and subjected to SDS^PAGE followed by
Western blot analysis. As shown in Fig. 5, all the fusion
proteins were overexpressed with expected molecular weights.
It is noteworthy, however, that a faint band with the molec-
ular weight of GFP can be detected in each lane. Although a
Kozak sequence was introduced immediately upstream of the
coding sequence in these vectors, the possibility that another
putative Kozak sequence and ATG start codon of GFP itself
may also serve as a weak translational initiator cannot be
excluded (see Fig. 1).
To assess the subcellular localization of TAT PTD, plas-
mids encoding GFP, His-TAT-GFP, His-TAT-m-GFP and
His-GFP were transiently transfected into A549 cells. At
48 h post-transfection, the GFP fusion protein expression
patterns were examined in living cells directly under a £uores-
cence microscope. The GFP from the control vector pEGFP-
N1 was found throughout cells in a di¡use cytoplasmic and
nuclear pattern (data not shown). In sharp contrast, His-
TAT-GFP was predominantly located in the nucleus and ac-
cumulated in the nucleolus, resulting in a very weak £uores-
cence in the cytoplasm (Fig. 6A). Addition of a His6 tag to the
N-terminus of GFP also yielded a di¡use £uorescence
throughout the cells, quite similar to GFP control protein
(Fig. 6B).
To further determine whether TAT PTD-mediated nuclear
localization was only restricted to A549 cells, monkey kidney
COS-7 cells (Fig. 6C,D) were transfected with the same plas-
mids used for A549 cells. Consistent with the observation
obtained from A549 cells, TAT-GFP fusion protein expressed
in COS-7 cells displayed e⁄cient nuclear and nucleolar im-
portation. Some other cell lines including HeLa, A172 and
HEK293T were also tested for nuclear targeting by TAT
PTD, and similar results were obtained (data not shown).
The expression in all these cells was allowed to continue for
up to 48 h and the GFP £uorescence was monitored periodi-
cally, but no visible changes in expression pattern were ob-
served.
Our results clearly demonstrate that TAT-GFP expressed in
mammalian cells was located predominantly in the nucleus,
and the majority was sequestered within the nucleolus. This
¢nding was consistent with previous observations that GFP
fused to full-length TAT protein resulted in nuclear/nucleolar
localization by using a transfection system [20] and also was
quite similar to the results reported by Vive's et al. using TAT
PTD-mediated protein transduction [6]. We observed very
faint cytoplasmic £uorescence present within the cells tested.
Currently we are not certain whether this represents a truly
cytoplasmically localized TAT-GFP or is the basal level ex-
pression resulting from a leaky expression of GFP protein per
se (see above). We believe that transfected expression and
localization of TAT PTD fusion protein might be more reli-
KDa        1             2             3             4       
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Fig. 5. Expression of TAT-GFP fusion proteins in mammalian cells.
HEK293T cells were transiently transfected with 1 Wg of various
mammalian expression constructs. At 48 h post-transfection, cell ly-
sates were subjected to Western blot analysis. Lane 1, pHis-TAT-
GFP; lane 2, pHis-TAT-m-GFP; lane 3, pHis-GFP; lane 4,
pEGFP-N1. Molecular size of protein is indicated on the left.
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able since subcellular compartment distribution of proteins
expressed within the cells has higher ¢delity compared with
transduced proteins expressed in E. coli.
To examine whether the TAT-GFP fusion proteins ex-
tracted from transfected mammalian cells could re-transduce
into a fresh cell monolayer, we extracted TAT-GFP from
transfected HeLa cells using the high-salt lysis bu¡er de-
scribed by Elliott et al. [21] and/or by sonication; the detec-
tion of £uorescence in fresh cultured cells was unsuccessful
when the transfected cell extract was exogenously added to
culture media. This result was not unexpected, since TAT
PTD, unlike VP22, is unable to confer its shuttling capacity
of exporting from the primary transfected cells and re-entering
the surrounding cells [5,20,22].
3.6. Mutant TAT peptide abolishes its ability of nuclear
targeting
To assess whether the mutations within TAT PTD could
a¡ect its capability of translocation and/or subcellular local-
ization, we substituted six out of 11 amino acids within the
TAT peptide. Basic amino acids (K and R) were changed to
the neutral amino acid alanine (A). Most changes took place
in the putative NLS region GRKKRR which now became
ARAAAR. The proposed protein translocation region RRR
was changed to ARA. This mutant variant TAT-m was pre-
viously reported to possess enhanced protein transduction po-
tential compared with the model structure TAT PTD [10].
However, in our hands we did not ¢nd that mutant TAT-m
was superior to the wild-type TAT PTD in terms of leading
the proteins to translocate across the cell membrane. To test
whether E. coli-expressed TAT-m-GFP was also able to e⁄-
ciently transduce into mammalian cells, TAT-m-GFP in either
denatured or native form was exogenously added to A172 cell
culture medium, and green £uorescence can only be barely
detected. This may be explained by the fact that the six-amino
acid substitution within the TAT PTD compromised its ability
to transduce into these particular A172 cells. In sharp contrast
to the nuclear/nucleolar localization of His-TAT-GFP, ectopi-
cally expressed His-TAT-m-GFP markedly abolished its abil-
ity to nuclear localization (Fig. 6E,F), indicating the function-
al signi¢cance of these basic amino acids.
In summary, we have successfully constructed a series of
prokaryotic and eukaryotic expression vectors for the purpose
of protein transduction and subcellular localization. Their
utilities have been tested by cloning and overexpression of
the genes encoding HSV-TK, Bcl-rambo, Smac/DIABLO
and GFP. The subcellular location of TAT or TAT-m was
assessed by generation of corresponding GFP fusion proteins.
The main features of these constructed vectors are (1) utiliza-
tion of an 11-amino acid HIV-1 TAT PTD for e⁄cient pro-
tein transduction and subcellular localization, (2) most favor-
able codons chosen for TAT peptide for elevated translation
initiation, (3) an additional Gly residue was introduced to aid
free bond rotation of TAT PTD, (4) addition of a His6 tag
greatly facilitates puri¢cation and detection, (5) interchange-
able MCS cassettes used for selection of cloning vectors, (7)
Fig. 6. Subcellular localization of TAT-GFP in transfected mammalian cells. A549 cells (A,B,E) and COS-7 cells (C,D,F) were transiently trans-
fected with 1 Wg of plasmids pHis-TAT-GFP (A,C), pHis-GFP (B,D) and pHis-TAT-m-GFP (E,F). At 48 h after transfection, the £uorescence
images (20U objective) were captured under the £uorescence microscope using Spot software.
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enhanced GFP used as a visible indicator for quickly moni-
toring eukaryotic expression and subcellular location, (8) mu-
tant TAT-m lacking NLS restricts the expressed proteins to
enter the nucleus. We believe that our constructed expression
vectors are ideally suited for high-level expression of foreign
genes and e⁄cient transduction of exogenously added pro-
teins. Many important researches rely on the gene products
to be localized at correct subcellular compartment(s) in order
to acquire their optimal activities. We believe our vectors may
provide useful tools to deliver therapeutic proteins into mam-
malian cells.
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